Monoclonal antibody candidate

Search documents
This Fidelity stock rockets over 70% on COVID-19 alternative vaccine; Time to buy?
Finbold· 2025-08-26 14:09
Invivyd (NASDAQ: IVVD), a biopharmaceutical company focused on developing protection against serious viral infectious diseases, is back in the spotlight with notable share price movement.IVVD shares closed Monday’s regular session at $0.56, but surged 73% to $0.97 in Tuesday’s pre-market trading following renewed attention on its monoclonal antibody candidate positioned as an alternative to traditional COVID-19 vaccines.Invivyd one-day stock price chart. Source: Google FinanceThe spike followed a report fro ...